South Korea
· Delayed Price · Currency is KRW Caregen Company Description
Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
The company offers filler products under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name.
It is also developing medicines for COVID-19 treatment, wet macular degeneration, dry macular degeneration, antiviral drugs, diabetic retinopathy, cataract, hyperhidrosis, pain relief, hair loss, obesity, psoriasis, wound, arthritis, and rhinitis; medical equipment for facial beauty, scalp/hair improvement, body care, and arthritis; cosmetics for wrinkle improvement, whitening, scalp/hair improvement, acne care, UV protection, atopy improvement, fine dust blocking, dark circles, cellulite reduction, and sebum secretion control; and food for blood sugar control, improved liver function, hangover cure, cholesterol control, and body fat reduction.
Caregen Co., Ltd. was founded in 2001 and is based in Anyang-Si, South Korea.
| Country | South Korea |
| Founded | 2001 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 180 |
| CEO | Yongji Chung |
Contact Details
Address: Caregen Building Anyang-Si, 14119 South Korea | |
| Phone | 82 3 1420 9200 |
| Website | caregen.co.kr |
Stock Details
| Ticker Symbol | 214370 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yongji Chung | Chief Executive Officer |